³í¹®) Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherpy in BRCA/2-mutated epi8thelial ovarian cancer: Amulticentre retrospective study ¿¬¼¼´ë ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú ÀÌÁ¤À± ±³¼ö, ÀÇ»ý¸í°úÇкΠ¹ÚÁØ½Ä ±³¼ö ¿¬±¸ÆÀ